Skeletal and Uterotrophic Effects of Endoxifen in Female Rats
Sign Up to like & getrecommendations! Published in 2017 at "Endocrinology"
DOI: 10.1210/en.2016-1871
Abstract: &NA; Endoxifen, the primary active metabolite of tamoxifen, is currently being investigated as a novel endocrine therapy for the treatment of breast cancer. Tamoxifen is a selective estrogen receptor modulator that elicits potent anti‐breast cancer… read more here.
Keywords: breast cancer; tamoxifen; bone loss; cancer ... See more keywords